APA (7th ed.) Citation

Patel, N. P., Guan, P., Bahal, D., Hashem, T., Scheuplein, F., Schaub, R., . . . Das, R. (2020). Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody. MDPI AG.

Chicago Style (17th ed.) Citation

Patel, Nishant P., Peng Guan, Devika Bahal, Tanwir Hashem, Felix Scheuplein, Robert Schaub, Kim E. Nichols, and Rupali Das. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody. MDPI AG, 2020.

MLA (8th ed.) Citation

Patel, Nishant P., et al. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody. MDPI AG, 2020.